About GeneDx
GeneDx is a company based in Gaithersburg (United States) founded in 2000 was acquired by Sema4 in January 2022.. The company has 1,000 employees as of December 31, 2024. GeneDx has completed 1 acquisition, including Fabric Genomics. GeneDx offers products and services including XomeDx, GenomeSeqDx, and GenomeXpress. GeneDx operates in a competitive market with competitors including Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others.
- Headquarter Gaithersburg, United States
- Employees 1000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genedx Holdings Corp.
-
Annual Revenue
$305.45 M50.79as on Dec 31, 2024
-
Net Profit
$-52.29 M70.25as on Dec 31, 2024
-
EBITDA
$492 K100.38as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Bioreference
& 1 more
-
Employee Count
1000
as on Dec 31, 2024
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GeneDx
GeneDx is a publicly listed company on the NASDAQ with ticker symbol WGS in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of GeneDx
GeneDx offers a comprehensive portfolio of products and services, including XomeDx, GenomeSeqDx, and GenomeXpress. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Test for diagnosing genetic disorders with higher yield than alternatives.
Comprehensive test including mitochondrial analysis for rare diseases.
Accelerates diagnosis for infants in intensive care units.
Unlock access to complete
Unlock access to complete
Leadership Team
20 people
Software Development Team
8 people
Finance and Accounting
7 people
Sales and Marketing
6 people
Operations Team
5 people
Board Team
5 people
Human Resources and Administration
4 people
Data Analysis and Operations Team
4 people
Unlock access to complete
Funding Insights of GeneDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GeneDx
GeneDx has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Bioreference and GeneDx. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pathology laboratory services are operated through a nationwide chain.
|
Founded Year | Domain | Location | |
|
Genome-based diagnostic solutions for reproductive health and oncology are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GeneDx
GeneDx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fabric Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-based disease diagnosis and genomic analysis tool for providers
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - GeneDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genedx Comparisons
Competitors of GeneDx
GeneDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genedx
Frequently Asked Questions about GeneDx
When was GeneDx founded?
GeneDx was founded in 2000.
Where is GeneDx located?
GeneDx is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
How many employees does GeneDx have?
As of Dec 31, 2024, the latest employee count at GeneDx is 1,000.
What is the annual revenue of GeneDx?
Annual revenue of GeneDx is $305.45M as on Dec 31, 2024.
What does GeneDx do?
Provider of genetic testing for inherited disorders. The company has CLIA certified labs that carry out genetic tests covering a range of medical specialties including cardiology, endocrinology, metabolic disorders, developmental disorders, hematology, immunology, oncology (hereditary cancer syndromes), among others. The company offers whole-exome sequencing with or without mitochondrial DNA sequencing, with or without reporting of incidental findings in the clinical reports.
Who are the top competitors of GeneDx?
GeneDx's top competitors include Natera, ImaginAb and Lantern Pharma.
What products or services does GeneDx offer?
GeneDx offers XomeDx, GenomeSeqDx, and GenomeXpress.
Is GeneDx publicly traded?
Yes, GeneDx is publicly traded on NASDAQ under the ticker symbol WGS.
How many acquisitions has GeneDx made?
GeneDx has made 1 acquisition, including Fabric Genomics.
Who are GeneDx's investors?
GeneDx has 2 investors. Key investors include Bioreference, and GeneDx.
What is GeneDx's ticker symbol?
The ticker symbol of GeneDx is WGS on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.